Epileptogenesis in a rat model of cortical malformation
Project Number5F30NS049727-02
Contact PI/Project LeaderTROTTER, STACEY A
Awardee OrganizationUNIVERSITY OF VIRGINIA
Description
Abstract Text
DESCRIPTION (provided by applicant):
Cortical malformations are commonly associated with medically-intractable epilepsies. A clear understanding of the role of such malformations in aberrant neural activity could provide insights for the treatment of these poorly managed disorders. This proposal will use a genetic animal model of a human cortical malformation, subcortical band heterotopia (SBH; or double cortex), in which large bilateral heterotopia are associated with spontaneous recurrent seizures. The rat model, termed "tish", provides unique opportunities for investigating both the development of malformations and mechanisms of epilepsy. Preliminary electrophysiological studies indicate that inhibitory GABAergic synaptic transmission is disturbed in the tish rat neocortex. Based on these observations, we hypothesize that altered inhibitory synaptic activity in the tish cortex predisposes the brain to seizures. Specific Aim 1 will characterize GABAergic synaptic inhibition in the tish rat neocortex using whole-cell patch clamp recording techniques in acute brain slices of the tish neocortex. It is important to note that GABAA receptors (GABAAR) undergo maturational changes in subunit composition during cortical development, and it is possible that this normal developmental process is disturbed in the tish cortex. Experiments will therefore be undertaken at multiple developmental time points during which key changes in GABAAR composition and function are known to occur. Specific Aim 2 will identify alterations in GABAAR subunits/subtypes, and GABA transporters in the developing and adult tish neocortex. Changes in these molecular substrates can affect the functional characteristics of GABAergic transmission, and any observed changes will be compared with the electrophysiological features defined in Aim 1. Together, these studies will elucidate fundamental features of a key inhibitory system in a dysplastic, seizure-prone brain.
National Institute of Neurological Disorders and Stroke
CFDA Code
853
DUNS Number
065391526
UEI
JJG6HU8PA4S5
Project Start Date
01-August-2004
Project End Date
31-July-2006
Budget Start Date
01-August-2005
Budget End Date
31-July-2006
Project Funding Information for 2005
Total Funding
$27,962
Direct Costs
$27,962
Indirect Costs
Year
Funding IC
FY Total Cost by IC
2005
National Institute of Neurological Disorders and Stroke
$27,962
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5F30NS049727-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5F30NS049727-02
Patents
No Patents information available for 5F30NS049727-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5F30NS049727-02
Clinical Studies
No Clinical Studies information available for 5F30NS049727-02
News and More
Related News Releases
No news release information available for 5F30NS049727-02
History
No Historical information available for 5F30NS049727-02
Similar Projects
No Similar Projects information available for 5F30NS049727-02